Exane Derivatives’s Albemarle ALB Stock Holding History

Exane Derivatives’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-942	Closed	-$208K	–	773
2022 Q1	$208K	Sell	942 -881	-48%	-$186K	0.06%	321
2021 Q4	$426K	Sell	1,823 -771	-30%	-$191K	0.1%	200
2021 Q3	$568K	Sell	2,594 -28	-1%	-$5.98K	0.14%	162
2021 Q2	$485K	Buy	+2,622	New	+$423K	0.11%	188
2021 Q1	–	Sell	-2,685	Closed	-$396K	–	895
2020 Q4	$396K	Buy	2,685 +556	+26%	+$66K	0.12%	203
2020 Q3	$190K	Sell	2,129 -305	-13%	-$27K	0.06%	212
2020 Q2	$188K	Buy	2,434 +1,620	+199%	+$110K	0.05%	218
2020 Q1	$45.9K	Buy	814 +471	+137%	+$36.1K	0.01%	358
2019 Q4	$27.5K	Sell	343 -112	-25%	-$7.48K	0.01%	385
2019 Q3	$31.6K	Hold	455	–	–	0.01%	386
2019 Q2	$32K	Buy	+455	New	+$33.6K	0.01%	410
2019 Q1	–	Sell	-13,184	Closed	-$1.02M	–	650
2018 Q4	$1.02M	Buy	13,184 +8,028	+156%	+$758K	0.18%	118
2018 Q3	$518K	Sell	5,156 -607	-11%	-$58.7K	0.1%	159
2018 Q2	$554K	Sell	5,763 -242	-4%	-$23.2K	0.09%	172
2018 Q1	$544K	Sell	6,005 -92	-2%	-$10.1K	0.11%	163
2017 Q4	$779K	Buy	6,097 +6,012	+7,073%	+$815K	0.13%	126
2017 Q3	$11.6K	Hold	85	–	–	﹤0.01%	386
2017 Q2	$8.97K	Sell	85 -1	-1%	-$109	﹤0.01%	398
2017 Q1	$9.08K	Sell	86 -4,325	-98%	-$421K	﹤0.01%	354
2016 Q4	$380K	Buy	+4,411	New	+$373K	0.07%	175

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's ALB Position: Q2 2022 in Review

Exane Derivatives sold out of Albemarle (ALB) in Q2 2022, closing a stake of 942 shares — an estimated $208K sold.

Exane Derivatives first reported a position in ALB in Q4 2016 and held it in 20 quarters. The position peaked at $1.02M in Q4 2018. 884 funds tracked by Wall St. Rank hold ALB as of Q2 2022.

Exane Derivatives reported no remaining Albemarle position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 942 Albemarle shares in Q2 2022, an estimated $208K.
Exane Derivatives first reported a position in Albemarle in Q4 2016 and held it in 20 quarters.
Exane Derivatives's Albemarle position peaked at $1.02M in Q4 2018.
884 funds tracked by Wall St. Rank held Albemarle as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.